1-((6-amino-9H-purin-9-yl)methyl)-4-(methylamino)cyclohexane-1,2-diol

ID: ALA5276433

Max Phase: Preclinical

Molecular Formula: C13H20N6O2

Molecular Weight: 292.34

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC1CCC(O)(Cn2cnc3c(N)ncnc32)C(O)C1

Standard InChI:  InChI=1S/C13H20N6O2/c1-15-8-2-3-13(21,9(20)4-8)5-19-7-18-10-11(14)16-6-17-12(10)19/h6-9,15,20-21H,2-5H2,1H3,(H2,14,16,17)

Standard InChI Key:  RVDGBSBNYFQHKG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -0.9036   -0.0151    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5810   -0.2440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4339   -0.6934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5793   -1.1012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2608    0.1596    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9087   -1.3395    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2421   -1.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9605   -0.2364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9651   -1.0678    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2413   -2.2412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6552    0.7351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1186    0.8952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6438    0.3091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4148    0.4666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6671    1.2159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1423    1.8081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3652    1.6510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4416    1.3732    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9651    0.7809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1603    2.2412    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0888    0.1367    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  2  0
  2  5  1  0
  3  6  2  0
  4  6  1  0
  4  7  1  0
  5  8  2  0
  7  9  2  0
  8  9  1  0
  7 10  1  0
  1 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 12 17  1  0
 16 17  1  0
 15 18  1  0
 18 19  1  0
 17 20  1  0
 12 21  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5276433

    ---

Associated Targets(Human)

METTL3 Tbio N6-adenosine-methyltransferase catalytic subunit (617 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 292.34Molecular Weight (Monoisotopic): 292.1648AlogP: -0.73#Rotatable Bonds: 3
Polar Surface Area: 122.11Molecular Species: BASEHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 13.25CX Basic pKa: 9.88CX LogP: -1.48CX LogD: -3.89
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.59Np Likeness Score: 0.74

References

1. Xu P, Ge R..  (2022)  Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy.,  230  [PMID:35063732] [10.1016/j.ejmech.2022.114118]

Source